Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 16.26
-0.13 (-0.79%)
Sep 9, 2026, 4:00 PM EDT
SHA:601089 Revenue
Beijing Foyou Pharma CO.,LTD had revenue of 898.98M CNY in the quarter ending June 30, 2026, with 11.88% growth. This brings the company's revenue in the last twelve months to 3.58B, up 4.57% year-over-year. In the year 2025, Beijing Foyou Pharma CO.,LTD had annual revenue of 3.50B with 1.71% growth.
Revenue (ttm)
3.58B
Revenue Growth
+4.57%
P/S Ratio
2.13
Revenue / Employee
916.23K
Employees
3,908
Market Cap
7.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.50B | 58.80M | 1.71% |
| Dec 31, 2024 | 3.45B | 106.01M | 3.17% |
| Dec 31, 2023 | 3.34B | 99.48M | 3.07% |
| Dec 31, 2022 | 3.24B | 402.44M | 14.18% |
| Dec 31, 2021 | 2.84B | 302.37M | 11.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 9.93B |
| China Animal Husbandry Industry | 6.58B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Zhejiang Tianyu Pharmaceutical | 3.50B |
| Jiuzhitang | 2.60B |
| Guilin Sanjin Pharmaceutical | 2.02B |
| Jinghua Pharmaceutical Group | 1.48B |
| Guangxi Wuzhou Zhongheng Group | 1.24B |